OCUL Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 3.50%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $340,138.76

Ocular Therapeutix Insider Trading History Chart

Ocular Therapeutix Share Price & Price History

^$5.90

▼ -0.12 (-1.99%)

As of 04/9/2025 02:02 PM ET

Days: 30 | 90 | 365

Ocular Therapeutix Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/24/2025	Pravin Dugel	Insider	Sell	21,475	$6.87	$147,533.25	3,520,318
2/4/2025	Donald Notman	Insider	Sell	11,119	$7.81	$86,839.39	193,444
1/31/2025	Donald Notman	Insider	Sell	6,301	$7.84	$49,399.84	204,563
11/25/2024	Jeffrey S. Heier	Insider	Sell	2,948	$9.01	$26,561.48	269,059
8/23/2024	Sanjay Nayak	Insider	Sell	1,832	$9.02	$16,524.64	176,194
5/23/2024	Sanjay Nayak	Insider	Sell	2,274	$5.84	$13,280.16	178,026
2/26/2024	Summer Road Llc	Major Shareholder	Buy	930,851	$7.52	$6,999,999.52	8,591,401
1/31/2024	Antony C. Mattessich	CEO	Sell	18,338	$4.95	$90,773.10	427,943
1/31/2024	Donald Notman	CFO	Sell	6,433	$4.95	$31,843.35	139,932
1/31/2024	Philip C Strassburger	General Counsel	Sell	6,831	$4.95	$33,813.45	109,218
1/31/2024	Rabia Gurses Ozden	Insider	Sell	7,764	$4.95	$38,431.80	92,767
8/30/2023	Antony C. Mattessich	CEO	Buy	6,500	$3.81	$24,765.00	6,500
7/7/2023	Rabia Gurses Ozden	Insider	Sell	832	$4.93	$4,101.76	100,531
2/6/2023	Antony C. Mattessich	CEO	Sell	19,669	$4.24	$83,396.56	446,281
2/6/2023	Christopher G White	Insider	Sell	5,829	$4.24	$24,714.96	94,766
2/6/2023	Donald Notman	CFO	Sell	6,476	$4.24	$27,458.24	139,387
2/6/2023	Philip C Strassburger	General Counsel	Sell	6,181	$4.24	$26,207.44	109,071
11/7/2022	Summer Road Llc	Major Shareholder	Buy	7,328	$3.50	$25,648.00	6,122,089
10/10/2022	Summer Road Llc	Major Shareholder	Buy	10,000	$4.00	$40,000.00	6,104,761
9/29/2022	Summer Road Llc	Major Shareholder	Buy	18,800	$4.04	$75,952.00	6,094,761
9/27/2022	Summer Road Llc	Major Shareholder	Buy	130,000	$4.68	$608,400.00	6,074,761

See Full Table

SEC Filings (Institutional Ownership Changes) for Ocular Therapeutix (NASDAQ:OCUL)

59.21% of Ocular Therapeutix stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Ocular Therapeutix Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/8/2025	Rhumbline Advisers	223,115	$1.64M	0.0%	+4.5%	0.140%
4/7/2025	GAMMA Investing LLC	8,232	$60K	0.0%	+6,760.0%	0.005%
3/24/2025	Wellington Management Group LLP	467,352	$3.99M	0.0%	+1.0%	0.294%
3/18/2025	California State Teachers Retirement System	91,998	$0.79M	0.0%	-7.3%	0.058%
2/25/2025	Polar Asset Management Partners Inc.	394,400	$3.37M	0.0%	-20.0%	0.251%
2/19/2025	GF Fund Management CO. LTD.	3,301	$28K	0.0%	N/A	0.002%
2/17/2025	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	218,588	$1.87M	0.0%	+48.0%	0.139%
2/17/2025	Voloridge Investment Management LLC	33,483	$0.29M	0.0%	-71.4%	0.021%
2/17/2025	Woodline Partners LP	1,002,435	$8.56M	0.1%	+0.2%	0.638%
2/17/2025	Two Sigma Advisers LP	36,700	$0.31M	0.0%	+252.9%	0.023%
2/17/2025	Two Sigma Investments LP	252,939	$2.16M	0.0%	+21.9%	0.161%
2/17/2025	Second Line Capital LLC	340,098	$2.90M	0.8%	+29.4%	0.216%
2/17/2025	Rafferty Asset Management LLC	15,222	$0.13M	0.0%	-17.4%	0.010%
2/17/2025	Point72 Asset Management L.P.	2,935,924	$25.07M	0.1%	+43.9%	1.867%
2/17/2025	Polar Asset Management Partners Inc.	394,400	$3.37M	0.0%	-20.0%	0.251%
2/17/2025	ProShare Advisors LLC	51,270	$0.44M	0.0%	+32.8%	0.033%
2/17/2025	Patient Square Capital LP	470,919	$4.02M	1.5%	+100.0%	0.300%
2/17/2025	Nuveen Asset Management LLC	414,104	$3.54M	0.0%	-17.6%	0.263%
2/17/2025	OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC	270,422	$2.31M	0.2%	+22.0%	0.172%
2/17/2025	Millennium Management LLC	447,237	$3.82M	0.0%	N/A	0.284%
2/17/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	88,463	$0.76M	0.0%	+3.3%	0.056%
2/17/2025	Graham Capital Management L.P.	37,577	$0.32M	0.0%	N/A	0.024%
2/17/2025	D. E. Shaw & Co. Inc.	31,419	$0.27M	0.0%	N/A	0.020%
2/17/2025	Deutsche Bank AG	456,120	$3.90M	0.0%	-45.3%	0.290%
2/17/2025	Deep Track Capital LP	12,836,282	$109.62M	4.1%	+0.9%	8.165%
2/17/2025	Cetera Investment Advisers	723,840	$6.18M	0.0%	+0.6%	0.460%
2/17/2025	Brevan Howard Capital Management LP	24,078	$0.21M	0.0%	N/A	0.015%
2/17/2025	Balyasny Asset Management L.P.	97,553	$0.83M	0.0%	N/A	0.062%
2/17/2025	Bank of America Corp DE	437,071	$3.73M	0.0%	-43.9%	0.278%
2/17/2025	BNP Paribas Financial Markets	75,400	$0.64M	0.0%	+110.6%	0.048%
2/17/2025	Ameriprise Financial Inc.	89,772	$0.77M	0.0%	+82.9%	0.057%
2/17/2025	Aptus Capital Advisors LLC	339,750	$2.90M	0.0%	+29.3%	0.216%
2/17/2025	Acuta Capital Partners LLC	1,111,071	$9.49M	9.5%	-6.6%	0.707%
2/14/2025	Freestone Grove Partners LP	13,931	$0.12M	0.0%	N/A	0.009%
2/14/2025	Nantahala Capital Management LLC	437,728	$3.74M	0.2%	-37.5%	0.278%
2/14/2025	Northern Trust Corp	1,314,871	$11.23M	0.0%	+5.5%	0.836%
2/14/2025	The Manufacturers Life Insurance Company	127,803	$1.09M	0.0%	-1.8%	0.081%
2/14/2025	Voya Investment Management LLC	371,235	$3.17M	0.0%	+35.7%	0.236%
2/14/2025	Adage Capital Partners GP L.L.C.	3,600,000	$30.74M	0.1%	-4.0%	2.290%
2/14/2025	Price T Rowe Associates Inc. MD	638,964	$5.46M	0.0%	-34.6%	0.406%
2/14/2025	Hsbc Holdings PLC	18,101	$0.15M	0.0%	+47.8%	0.012%
2/14/2025	Tower Research Capital LLC TRC	8,859	$76K	0.0%	+2,045.0%	0.006%
2/14/2025	MetLife Investment Management LLC	92,734	$0.79M	0.0%	+2.7%	0.059%
2/14/2025	First Trust Advisors LP	212,944	$1.82M	0.0%	N/A	0.135%
2/13/2025	CANADA LIFE ASSURANCE Co	30,227	$0.26M	0.0%	+152.4%	0.019%
2/13/2025	Walleye Capital LLC	10,548	$90K	0.0%	N/A	0.007%
2/13/2025	XTX Topco Ltd	11,593	$99K	0.0%	N/A	0.007%
2/13/2025	Barclays PLC	331,242	$2.83M	0.0%	-35.2%	0.211%
2/13/2025	Raymond James Financial Inc.	201,623	$1.72M	0.0%	N/A	0.128%
2/13/2025	Legal & General Group Plc	104,783	$0.90M	0.0%	-8.1%	0.067%
2/13/2025	Invesco Ltd.	890,046	$7.60M	0.0%	+17.8%	0.566%
2/13/2025	Wells Fargo & Company MN	74,208	$0.63M	0.0%	-83.7%	0.047%
2/12/2025	Atlas Capital Advisors Inc.	5,000	$43K	0.0%	N/A	0.003%
2/12/2025	Nottingham Advisors Inc.	97,828	$0.84M	0.1%	-47.3%	0.062%
2/12/2025	Geode Capital Management LLC	3,236,312	$27.64M	0.0%	-1.1%	2.058%
2/12/2025	Wellington Management Group LLP	467,352	$3.99M	0.0%	+1.0%	0.297%
2/12/2025	JPMorgan Chase & Co.	189,295	$1.62M	0.0%	+123.6%	0.120%
2/12/2025	Artisan Partners Limited Partnership	1,334,702	$11.40M	0.0%	+26.4%	0.849%
2/11/2025	Corebridge Financial Inc.	77,362	$0.66M	0.0%	-7.0%	0.049%
2/11/2025	Vanguard Group Inc.	8,483,913	$72.45M	0.0%	+1.2%	5.396%
2/11/2025	KLP Kapitalforvaltning AS	17,400	$0.15M	0.0%	N/A	0.011%
2/11/2025	Sei Investments Co.	27,742	$0.24M	0.0%	+19.3%	0.018%
2/11/2025	Rosalind Advisors Inc.	1,128,700	$9.64M	4.8%	+27.5%	0.718%
2/11/2025	Teacher Retirement System of Texas	27,777	$0.24M	0.0%	+10.0%	0.018%
2/10/2025	Cibc World Markets Corp	14,562	$0.12M	0.0%	N/A	0.009%
2/10/2025	Swiss National Bank	184,000	$1.57M	0.0%	-7.0%	0.117%
2/7/2025	Essex Investment Management Co. LLC	387,248	$3.31M	0.6%	-12.7%	0.246%
2/7/2025	AlphaQuest LLC	6,162	$53K	0.0%	N/A	0.004%
2/7/2025	Banco Santander S.A.	151,107	$1.29M	0.0%	-12.3%	0.096%
2/6/2025	Raymond James Financial Inc.	201,623	$1.72M	0.0%	N/A	0.128%
2/6/2025	Arizona State Retirement System	27,121	$0.23M	0.0%	-6.4%	0.017%
2/6/2025	Aigen Investment Management LP	18,588	$0.16M	0.0%	N/A	0.012%
2/6/2025	Victory Capital Management Inc.	68,871	$0.59M	0.0%	+300.4%	0.044%
2/6/2025	Charles Schwab Investment Management Inc.	1,131,485	$9.66M	0.0%	+1.9%	0.720%
2/4/2025	Bank of New York Mellon Corp	420,231	$3.59M	0.0%	-1.0%	0.267%
2/3/2025	Hussman Strategic Advisors Inc.	105,000	$0.90M	0.3%	N/A	0.067%
1/31/2025	New York State Common Retirement Fund	98,097	$0.84M	0.0%	+18.4%	0.062%
1/31/2025	Truist Financial Corp	50,000	$0.43M	0.0%	N/A	0.032%
1/30/2025	Palumbo Wealth Management LLC	11,693	$100K	0.0%	N/A	0.007%
1/30/2025	Rhumbline Advisers	213,601	$1.82M	0.0%	+2.7%	0.136%
1/29/2025	Legato Capital Management LLC	114,820	$0.98M	0.1%	-23.2%	0.073%
1/27/2025	Deltec Asset Management LLC	2,616,373	$22.34M	4.4%	+0.6%	1.664%
1/24/2025	China Universal Asset Management Co. Ltd.	33,336	$0.29M	0.0%	+11.2%	0.021%
1/17/2025	SG Americas Securities LLC	71,698	$0.61M	0.0%	+58.7%	0.046%
1/16/2025	RoundAngle Advisors LLC	198,456	$1.70M	1.6%	N/A	0.126%
1/13/2025	Courier Capital LLC	56,438	$0.48M	0.0%	N/A	0.036%
12/19/2024	Principal Financial Group Inc.	14,561	$0.13M	0.0%	-44.8%	0.009%
11/16/2024	Geode Capital Management LLC	3,271,207	$28.46M	0.0%	-5.2%	2.098%
11/15/2024	Barclays PLC	511,522	$4.45M	0.0%	+37.1%	0.325%
11/15/2024	Wellington Management Group LLP	462,864	$4.03M	0.0%	+47.1%	0.297%
11/15/2024	State Street Corp	3,476,292	$30.24M	0.0%	-11.3%	2.230%
11/15/2024	Point72 Asset Management L.P.	2,040,620	$17.75M	0.0%	-24.6%	1.309%
11/15/2024	Polar Asset Management Partners Inc.	492,900	$4.29M	0.1%	N/A	0.316%
11/15/2024	Patient Square Capital LP	235,498	$2.05M	0.8%	N/A	0.151%
11/15/2024	HighVista Strategies LLC	65,027	$0.57M	0.2%	+5.1%	0.042%
11/15/2024	Erste Asset Management GmbH	235,800	$2.05M	0.0%	N/A	0.151%
11/14/2024	PFM Health Sciences LP	402,843	$3.51M	0.2%	N/A	0.258%
11/14/2024	Braidwell LP	2,239,770	$19.49M	0.6%	+36.3%	1.436%
11/14/2024	Knoll Capital Management LLC	600,400	$5.22M	2.6%	+199.6%	0.385%
11/14/2024	Verition Fund Management LLC	62,501	$0.54M	0.0%	N/A	0.040%

Data available starting January 2016

See Full Table

Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology in the United States. The company markets DEXTENZA, a dexamethasone ophthalmic insert to treat post-surgical ocular inflammation and pain following ophthalmic surgery, as well as allergic conjunctivitis. It is developing AXPAXLI, an axitinib intravitreal implant that is in phase 3 trials for the treatment of wet age-related macular degeneration and other retinal diseases; PAXTRAVA, a travoprost intracameral implant, which is in phase 2 clinical trials for the treatment of open-angle glaucoma or ocular hypertension; OTX-CSI, a cyclosporine intracanalicular insert that has completed phase 2 clinical trials for the treatment of dry eye disease; and OTX-DED, a dexamethasone intracanalicular insert, which is in phase 2 clinical trials for the short-term treatment of the signs and symptoms of dry eye disease. In addition, the company offers modulator for intermediate and late dry age-related macular degeneration; and gene delivery for inherited retinal degenerations and protein biofactory indications. The company has a strategic collaboration with Regeneron Pharmaceuticals, Inc. (Regeneron) for the development and commercialization of products using the company's sustained-release hydrogel in combination with Regeneron's large molecule VEGF-targeting compounds for the treatment of retinal diseases; and AffaMed Therapeutics Limited for the development and commercialization of DEXTENZA and OTX-TIC. Ocular Therapeutix, Inc. was incorporated in 2006 and is headquartered in Bedford, Massachusetts.

Today's Range

Now: $5.90

$5.80

$6.19

50 Day Range

MA: $7.31

$5.93

$8.51

52 Week Range

Now: $5.90

$4.06

$11.77

Volume

742,136 shs

Average Volume

1,319,736 shs

Market Capitalization

$938.23 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.49

Who are the company insiders with the largest holdings of Ocular Therapeutix?: Ocular Therapeutix's top insider investors include:
Summer Road Llc (Major Shareholder)
Pravin Dugel (Insider)
Antony C Mattessich (CEO)
Jeffrey S Heier (Insider)
Donald Notman (Insider)
Sanjay Nayak (Insider)
Donald Notman (CFO)
Philip C Strassburger (General Counsel)
Rabia Gurses Ozden (Insider)
Learn More about top insider investors at Ocular Therapeutix.
Who are the major institutional investors of Ocular Therapeutix?: Ocular Therapeutix's top institutional investors include:
Rhumbline Advisers — 0.14%
GAMMA Investing LLC — 0.01%
Learn More about top institutional investors of Ocular Therapeutix stock.
Which major investors are buying Ocular Therapeutix stock?: Within the last quarter, OCUL stock was acquired by institutional investors including:
Rhumbline Advisers
GAMMA Investing LLC
During the last year, these company insiders have bought Ocular Therapeutix stock:
Summer Road Llc (Major Shareholder)
Pravin Dugel (Insider)
Learn More investors buying Ocular Therapeutix stock.